Vayas360 lines up $25 million lead investment from AND Capital Ventures

Vayas360 said June 23 it entered into an agreement for a proposed $25 million lead investment from AND Capital Ventures to help anchor its first close. The deal would support an acquisition-led push to build a personalized health platform that combines diagnostics, nutrition, coaching and practitioner-guided care.

Why it matters: - The proposed investment would give Vayas360 a financial anchor for its current raise and help fund an acquisition-driven strategy. - Vayas360 is trying to build an integrated personalized health platform, a model aimed at serving consumers, patients, practitioners, employers and payer partners. - The company’s approach could connect clinical care, nutrition and data tracking into one system, which may matter for cardiometabolic risk, longevity and women’s health.

What happened: - Vayas360 announced June 23 that it entered into an agreement for a proposed $25 million institutional lead investment from AND Capital Ventures. - The proposed capital is expected to anchor the first close of Vayas360’s current raise. - The announcement said the investment would support Vayas360’s acquisition-led platform strategy. - Vayas360 said it is acquiring a Food Is Medicine Coalition-accredited medically tailored meals operator with payer relationships and accredited therapeutic programs.

The details: - Vayas360 said the acquisition is the first operational layer in a broader plan to assemble an integrated ecosystem spanning diagnostics through practitioner-guided care. - The company described its model as combining diagnostics, testing, therapeutic nutrition, supplementation, wearable integration, health coaching and practitioner-guided support. - Vayas360 uses the term “Vayaspan” for the personalized span of life where energy, metabolic resilience, strength, cognitive clarity and confidence work together. - Vayas360 said the platform is expected, if developed as planned, to generate longitudinal outcomes data at the individual level. - AND Capital Ventures is an AI-native, operator-led private equity and growth capital platform. - AND Capital Ventures said it focuses on high-conviction sectors where operational complexity can create durable advantage. - The firm operates with team members across Calgary, Austin, New York, Boston and London. - Dr. Denise Brown serves as general partner of AND Capital Ventures’ Health and Wellness Innovation Fund and has more than 30 years of clinical and business leadership scaling healthcare organizations. - Vayas360 said it serves consumers, patients, practitioners, employers and payer partners.

Between the lines: - The announcement signals more than a financing round. Vayas360 is pairing capital with M&A to assemble capabilities faster than a single-product rollout would allow. - The language around “healthspan” and “longevity” suggests Vayas360 is pitching a platform built for prevention and ongoing engagement, not just episodic care. - The repeated focus on payer relationships and longitudinal data points to a business model that may aim to prove clinical and commercial value over time. - The forward-looking statements in the release make clear the deal is not yet final and remains subject to definitive documentation, approvals, market conditions and other closing factors.

What’s next: - Vayas360 said the proposed investment remains subject to the completion of definitive documentation and other closing conditions. - The company said the broader financing and acquisition plans could be delayed, restructured or may not occur. - If the transaction closes, Vayas360 plans to keep building through multiple acquisitions rather than a single product launch. - More information is available on Vayas360's website and AND Capital Ventures' website.

The bottom line: - Vayas360 is trying to turn a proposed $25 million lead investment into the foundation for a broader personalized health platform, with acquisitions as the main growth engine.